| Action Summary | DMAS has incorporated changes to the state plan text related to the Drug Utilization Review Program in accordance with the requirements of the Support Act (Public Law No. 115-271). The changes include Support Act provisions related to: claims review limitations; a program to monitor antipsychotic medications by children; fraud and abuse identification; and Medicaid managed care organizations requirements. This regulatory action incorporates the same changes into the Virginia Administrative Code. |
| Chapters Affected | Only affects this chapter. |
| Executive Branch Review | This action will go through the normal Executive Branch Review process. |
| RIS Project | Yes [006136] |
|
Is Federal action a driving factor in this regulatory change? If so, please provide a specific reference to the law, regulation
or court case.
Support Act (Public Law No. 115-271)
|
|
| New Periodic Review | This action will not be used to conduct a new periodic review. |
| Stage ID | Stage Type | Status |
|---|---|---|
| 8942 | Fast-Track | Stage complete. This regulation became effective on 09/02/2021. |
| Name / Title: | Emily McClellan / Regulatory Supervisor |
| Address: |
Policy Division, DMAS 600 East Broad St., Suite 1300 Richmond, VA 23219 |
| Email Address: | Emily.McClellan@DMAS.Virginia.gov |
| Phone: | (804)371-4300 FAX: (804)786-1680 TDD: ()- |